Featured Research

Vanderbilt Blair School of Music’s Blair Big Band is among 10 outstanding college jazz orchestras from across the nation invited to participate in the third annual Jack Rudin Jazz Championship. The event, which will be Jan. 14 and 15 at Jazz at Lincoln Center in New York City, will include workshops, performances and a high-level collegiate competition. Read More

Vanderbilt University was part of a consortium of academic researchers, working with leading automakers, that recently concluded a five-day test on a stretch of I-24 near downtown Nashville—the largest study of its kind in the world. The researchers tested an AI-powered cruise control system designed to increase fuel savings and ease traffic. Read More

Researchers in the Vanderbilt University School of Medicine have received three grants totaling $13.6 million from the National Institutes of Health to develop molecular “atlases” of the brain, kidney, eye and other tissues. Read More

Lisa Monteggia, Barlow Family Director of the Vanderbilt Brain Institute and professor of pharmacology, and Ege Kavalali, chair of the Department of Pharmacology and William Stokes Professor of Experimental Therapeutics, have been awarded the first prize by the Anna-Monika Foundation. Read More

Warren Center for Neuroscience Drug Discovery lead researchers discover a therapy that may treat memory loss and slow the progression of Alzheimer’s disease. Read More

The CIRCLES Consortium, consisting of Vanderbilt University and several other universities, in coordination with Nissan North America, Toyota, GM, and the Tennessee Department of Transportation, will test 100 AI-equipped vehicles in an effort to mitigate human-caused traffic jams. Read More

The U.S. Supreme Court will again review the constitutionality of affirmative action Oct. 31 when it hears the cases of Students for Fair Admissions, Inc. v. Presidents and Fellows of Harvard College and Students for Fair Admissions, Inc. v. University of North Carolina. Assistant Professor of Higher Education and Public Policy Kelly Slay will join many of her colleagues in Washington, D.C., to engage in rallies related to these cases. Read More

Research in the Weaver lab leads to discoveries that help secure partnership with Ancora Innovation LLC.  “Vanderbilt is at the forefront of genetic research. By understanding the genetic causes of disease opens exciting new opportunities to develop drugs to treat them more effectively,” said Matt Nelson, vice president, genetics and genomics, 3DC at Deerfield Management.  Read More

Antentor Hinton Jr., assistant professor of molecular physiology and biophysics in the School of Medicine Basic Sciences, has been awarded a $1.15 million, five-year grant from the Chan Zuckerberg Initiative to boost diversity in STEM research. Read More

Christopher Carpenter, Lisa M. Monteggia and W. Kimryn Rathmell have been elected to the National Academy of Medicine for their major contributions to the advancement of medical science, health care and public policy. Read More

Discovery Vanderbilt, announced today by Provost C. Cybele Raver, builds upon Opportunity Vanderbilt and Destination Vanderbilt by committing major resources to dramatically increase faculty, student and staff engagement and success in pursuing bold new ideas through disciplined, rigorous inquiry. Read More

The Vanderbilt Innovation Ambassadors Program is an initiative to provide Vanderbilt and Vanderbilt University Medical Center researchers with better peer-delivered access to assistance and information about innovation and entrepreneurship on campus. Read More

Audrey Bowden, Dorothy J. Wingfield Phillips Chancellor’s Faculty Fellow and associate professor of biomedical and electrical engineering, has won a grant from the National Institute of Biomedical Imaging and Bioengineering to develop a novel noninvasive smartphone-integrated device to provide accurate, point-of-care detection of jaundice in newborns of all skin tones. Read More

Cynthia Reinhart-King was among a handful of national experts invited to participate in the White House Summit on Biotechnology and Biomanufacturing for the American Bioeconomy. The event marked the launch of a new initiative to develop bio-based solutions to global challenges ranging from food security and climate change to health security and supply chain disruptions.  Read More

In this international research cooperation, Vanderbilt is leading the development of AI to automatically localize and count monkeypox lesions, the main measure of disease severity, and spearheading a guideline to classify monkeypox lesions. Read More

Vanderbilt University has been chosen by the National Science Foundation to lead the new Mid-South Innovation Corps Hub, a group of nine universities that make up a regional coalition of diverse, tech-forward institutions to promote inclusive innovation, spur economic development and prosperity and transform Midsouth metro areas into growth and commercialization centers for STEM-related technologies. Read More

Julián F. Hillyer, professor of biological sciences, and his research team discovered how mosquito immune and circulatory systems are related. This work may lead to the development of novel strategies that protect beneficial insects or harm detrimental ones. Read More

Alvin Jeffery awarded $1.5M from the National Institute on Drug Abuse to develop artificial intelligence to predict substance use disorder through genetic information. Jeffery is the only nursing research faculty member with a dual VA appointment. Read More

Vanderbilt University Medical Center nurses are collaborating with Metro Nashville Public Schools to mentor high school students who have identified a future goal of becoming a registered nurse to be medical assistants or care partners. Read More

Dr. James Crowe, Robert Carnahan and their colleagues in the Vanderbilt Vaccine Center won the Gold medal in the 2022 R&D 100 awards for their discovery and development of long-acting antibodies that protect against COVID-19. The discovery of these antibodies has led to the development of Evusheld, pre-exposure therapy to prevent COVID-19 for adults and children over 12 with compromised immune systems or a history of severe adverse reactions to a COVID-19 vaccine. Read More